MedTrace Logo

Nebula Study - Screener Apps and HSAT vs. PSG Comparison

NCT04597749 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2021-02-04

No results posted yet for this study

Summary

This is a prospective, unblinded, open-label, single group study. All subjects will undergo concurrent screener app, HSAT testing, and in-lab polysomnography.

Conditions

  • Sleep Apnea, Obstructive

Interventions

DIAGNOSTIC_TEST

PSG

In-lab sleep polysomnography test

DIAGNOSTIC_TEST

Home Sleep Apnea Test with FDA cleared devices

In-lab HST test

OTHER

Non-Contact Screening App

Non-Contact Sleep Apnea Screening Applications at bedside table to assess for sleep apnea.

Sponsors & Collaborators

  • ResMed

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-10-27
Primary Completion
2020-12-31
Completion
2021-01-20
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04597749 on ClinicalTrials.gov